Two Sigma Investments
NAMS icon

Two Sigma Investments’s NewAmsterdam Pharma NAMS Stock Holding History

Two Sigma Investments’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,392
Closed -$514K – 3826
2025
Q2 		$514K Sell
28,392
-13,466
-32% -$246K ﹤0.01% 2577
2025
Q1 		$857K Sell
41,858
-47,731
-53% -$1.06M ﹤0.01% 2262
2024
Q4 		$2.3M Sell
89,589
-140,508
-61% -$2.98M 0.01% 1620
2024
Q3 		$3.82M Buy
230,097
+143,800
+167% +$2.49M 0.01% 1227
2024
Q2 		$1.66M Buy
86,297
+34,622
+67% +$695K ﹤0.01% 1671
2024
Q1 		$1.22M Buy
+51,675
New +$1.05M ﹤0.01% 1825

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments's NAMS Position: Q3 2025 in Review

Two Sigma Investments sold out of NewAmsterdam Pharma (NAMS) in Q3 2025, closing a stake of 28,392 shares — an estimated $514K sold.

Two Sigma Investments first reported a position in NAMS in Q1 2024 and held it in 6 quarters. The position peaked at $3.82M in Q3 2024. 137 funds tracked by Wall St. Rank hold NAMS as of Q3 2025.

  • Two Sigma Investments reported no remaining NewAmsterdam Pharma position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Investments sold 28,392 NewAmsterdam Pharma shares in Q3 2025, an estimated $514K.
  • Two Sigma Investments first reported a position in NewAmsterdam Pharma in Q1 2024 and held it in 6 quarters.
  • Two Sigma Investments's NewAmsterdam Pharma position peaked at $3.82M in Q3 2024.
  • 137 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.